Study aims to stop the revolving door of c. diff infections
NCT ID NCT04138706
Summary
This study tested if adding a two-week tapering dose of the antibiotic vancomycin after the standard 14-day treatment could prevent C. difficile infection (CDI) from coming back. It involved 263 adults who had just finished treatment for their first or second CDI. Participants were randomly assigned to receive either the extra tapering dose or a placebo pill for two weeks to see which group had fewer recurrences.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CLOSTRIDIUM DIFFICILE INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre hospitalier universitaire de Sherbrooke
Sherbrooke, Quebec, J1H 5N4, Canada
-
Health Sciences Centre - Eastern Health
St. John's, Newfoundland and Labrador, A1B 3V6, Canada
-
Jewish General Hospital
Montreal, Quebec, H3T 1E2, Canada
-
Kingston Health Sciences Centre
Kingston, Ontario, K7L 2V7, Canada
-
McGill University Health Centre (Royal Victoria Hospital)
Montreal, Quebec, H4A3J1, Canada
-
Michael Garron Hospital
Toronto, Ontario, M4C 3E7, Canada
-
St Joseph's Health Care
Toronto, Ontario, M6R 1B5, Canada
-
St. Michael's Hospital
Toronto, Ontario, M5B 1W8, Canada
-
Sunnybrook Health Science Centre
Toronto, Ontario, M4N 3M5, Canada
-
The Ottawa Hospital
Ottawa, Ontario, K1Y 4E9, Canada
-
University Health Network
Toronto, Ontario, M5G 1L7, Canada
-
Vancouver General Hospital
Vancouver, British Columbia, V5Z 1M9, Canada
Conditions
Explore the condition pages connected to this study.